SCHEMBL29323912

SCHEMBL29323912

COC(=O)c1ncc(C2CNCCN2)cc1NC(=O)OC(C)(C)C

nearest known ligand 0.34

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
ATR Q13535 1/20 0.34
DGAT1 O75907 1/20 0.32
METAP1 P53582 1/20 0.31
RECQL P46063 1/20 0.31
RORC P51449 3/20 0.30
GSK3B P49841 1/20 0.30
DYRK1A Q13627 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29323913 0.78 RORC (0.33) RORC
SCHEMBL23500611 0.73 ATR (0.42) ATRMETAP1RORCGSK3BDYRK1A
SCHEMBL29323901 0.73 AAK1 (0.46) ATRMETAP1RECQLRORCGSK3B
SCHEMBL21339691 0.73 ATR (0.42) ATRMETAP1GSK3BDYRK1A
SCHEMBL29060089 0.71 RXFP1 (0.44) ATRMETAP1
SCHEMBL29323903 0.67 ATR (0.40) ATRMETAP1
SCHEMBL26071946 0.66 ATR (0.42) ATR
SCHEMBL29812170 0.66 ATR (0.42) ATR
SCHEMBL4345991 0.65 METAP1 (0.62) ATRMETAP1
SCHEMBL12583021 0.65 ATR (0.43) ATRMETAP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024148274-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2024-07-11 WO disclosed
WO-2024148274-A1 COMPLEMENT INHIBITION APELLIS PHARMACEUTICALS, INC. (US) 2024-07-11 WO disclosed